当前位置:首页 - 行情中心 - 睿智医药(300149) - 财务分析 - 现金流量表

睿智医药

(300149)

  

流通市值:46.55亿  总市值:48.85亿
流通股本:4.75亿   总股本:4.98亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金812,104,041.96533,876,099.3239,553,771.911,004,001,952.96
  收到的税费返还29,282,855.4919,989,504.512,613,698.7837,662,126
  收到其他与经营活动有关的现金23,662,504.0229,151,254.935,777,305.1731,965,640.55
  经营活动现金流入小计865,049,401.47583,016,858.73257,944,775.861,073,629,719.51
  购买商品、接受劳务支付的现金309,756,724.28215,206,485.71101,349,015.83288,669,738.97
  客户贷款及垫款净增加额---0
  存放中央银行和同业款项净增加额---0
  支付原保险合同赔付款项的现金---0
  支付利息、手续费及佣金的现金---0
  支付保单红利的现金---0
  支付给职工以及为职工支付的现金396,424,765.31273,972,450.02138,759,519.4539,393,030.71
  支付的各项税费15,441,909.6710,911,502.021,330,160.3812,247,988.77
  支付其他与经营活动有关的现金23,190,832.0917,591,336.596,447,333.4965,111,669.98
  经营活动现金流出的其他项目---0
  经营活动现金流出小计744,814,231.35517,681,774.34247,886,029.1905,422,428.43
  经营活动产生的现金流量净额120,235,170.1265,335,084.3910,058,746.76168,207,291.08
二、投资活动产生的现金流量:
  收回投资收到的现金30,00030,00030,000-
  取得投资收益收到的现金24,395.5223,695.95230.14228,438.57
  处置固定资产、无形资产和其他长期资产收回的现金净额30,064,162.6430,003,3502,210160,754.25
  收到的其他与投资活动有关的现金49,282,542.9231,555,864.86600,090.186,832,022.29
  投资活动现金流入小计79,401,101.0861,612,910.81632,530.327,221,215.11
  购建固定资产、无形资产和其他长期资产支付的现金41,657,076.1230,068,772.958,182,154.4269,245,662.07
  投资支付的现金10,050,00010,050,000--
  支付其他与投资活动有关的现金82,180,00049,700,0003,800,0005,644,000
  投资活动现金流出小计133,887,076.1289,818,772.9511,982,154.4274,889,662.07
  投资活动产生的现金流量净额-54,485,975.04-28,205,862.14-11,349,624.1-67,668,446.96
三、筹资活动产生的现金流量:
  取得借款收到的现金5,000,0001,000,000-21,000,000
  收到其他与筹资活动有关的现金35,300,00035,300,000-37,450,000
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计40,300,00036,300,000-58,450,000
  偿还债务支付的现金14,260,0004,260,000-54,280,000
  分配股利、利润或偿付利息支付的现金1,335,912.181,178,828.85-149,780.992,876,300.4
  支付其他与筹资活动有关的现金89,756,965.7980,670,392.4919,579,961.2887,730,047.94
  筹资活动现金流出小计105,352,877.9786,109,221.3419,430,180.29144,886,348.34
  筹资活动产生的现金流量净额-65,052,877.97-49,809,221.34-19,430,180.29-86,436,348.34
四、汇率变动对现金及现金等价物的影响-1,754,786.44633,349.4314,695.077,117,000.81
五、现金及现金等价物净增加额-1,058,469.33-12,046,649.69-20,406,362.5621,219,496.59
  加:期初现金及现金等价物余额363,448,871.8363,448,871.8363,406,399.37342,229,375.21
  期末现金及现金等价物余额362,390,402.47351,402,222.11343,000,036.81363,448,871.8
补充资料:
  净利润-25,345,366.23--226,512,315.17
  资产减值准备-14,443,974.16-186,446,098.54
  固定资产和投资性房地产折旧-28,185,850.01-57,171,171.27
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-28,185,850.01-57,171,171.27
  无形资产摊销-1,457,197.75-2,392,617.35
  长期待摊费用摊销-22,678,784.45-47,750,799.44
  处置固定资产、无形资产和其他长期资产的损失--6,261,722.68--8,433,398.14
  固定资产报废损失-368,870.39-14,689,405.13
  公允价值变动损失-15,167.73-2,296,500
  财务费用-6,333,606.42-14,414,314.05
  投资损失--12,893,493.74--10,091,924.67
  递延所得税--1,642,109.91--8,716,557.55
  其中:递延所得税资产减少--2,345,794.3-987,549.95
    递延所得税负债增加-703,684.39--9,704,107.5
  存货的减少--1,976,714.9-7,011,672.96
  经营性应收项目的减少--44,063,422.47-58,805,332.1
  经营性应付项目的增加--355,188.92--41,244,096.99
  其他-1,892,070.64--
  现金的期末余额-351,402,222.11-363,448,871.8
  减:现金的期初余额-363,448,871.8-342,229,375.21
  现金及现金等价物的净增加额--12,046,649.69-21,219,496.59
公告日期2025-10-302025-08-292025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑